Free Trial

IMAX (IMAX) Stock Forecast & Price Target

IMAX logo
$24.76 -0.14 (-0.56%)
(As of 11/20/2024 ET)

IMAX - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
1
Buy
8

Based on 10 Wall Street analysts who have issued ratings for IMAX in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 10 analysts, 1 has given a sell rating, 1 has given a hold rating, 7 have given a buy rating, and 1 has given a strong buy rating for IMAX.

Consensus Price Target

$24.22
-2.17% Downside
According to the 10 analysts' twelve-month price targets for IMAX, the average price target is $24.22. The highest price target for IMAX is $30.00, while the lowest price target for IMAX is $13.00. The average price target represents a forecasted downside of -2.17% from the current price of $24.76.
Get the Latest News and Ratings for IMAX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for IMAX and its competitors.

Sign Up

IMAX Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$24.22$24.11$23.56$23.43
Forecasted Upside-2.17% Downside17.21% Upside10.23% Upside42.94% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

IMAX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

IMAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

IMAX Stock vs. The Competition

TypeIMAXConsumer Discretionary CompaniesS&P 500
Consensus Rating Score
2.80
2.56
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-2.17% Downside1,133.18% Upside9.81% Upside
News Sentiment Rating
Neutral News

See Recent IMAX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/31/2024Roth Mkm
1 of 5 stars
 Boost TargetBuy ➝ Buy$27.00 ➝ $28.00+16.52%
10/31/2024Barrington Research
4 of 5 stars
 Reiterated RatingOutperform ➝ Outperform$24.00 ➝ $24.00+10.50%
10/31/2024Rosenblatt Securities
3 of 5 stars
 Reiterated RatingBuy ➝ Buy$28.00 ➝ $28.00+28.91%
10/14/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$20.00 ➝ $21.00-2.28%
9/3/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$24.00 ➝ $26.00+20.76%
7/26/2024Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$24.00 ➝ $26.00+30.39%
7/24/2024Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Joyce
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/8/2024B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$27.00 ➝ $30.00+73.31%
6/20/2024Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$22.00 ➝ $22.00+35.72%
1/11/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSell ➝ Sell$15.00 ➝ $13.00-11.44%
2/13/2023Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
E. Handler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:35 AM ET.


IMAX Forecast - Frequently Asked Questions

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for IMAX is $24.22, with a high forecast of $30.00 and a low forecast of $13.00.

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IMAX in the last twelve months. There is currently 1 sell rating, 1 hold rating, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" IMAX shares.

According to analysts, IMAX's stock has a predicted downside of -2.17% based on their 12-month stock forecasts.

IMAX has been rated by research analysts at Barrington Research, JPMorgan Chase & Co., Rosenblatt Securities, Roth Mkm, and Wedbush in the past 90 days.

Analysts like IMAX more than other "consumer discretionary" companies. The consensus rating score for IMAX is 2.80 while the average consensus rating score for "consumer discretionary" companies is 2.56. Learn more on how IMAX compares to other companies.


This page (NYSE:IMAX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners